“CA Rudramurthy BV is bullish on Aurobindo Pharma, identifying it as a buying opportunity on dips due to overall market weakness. He notes the stock has consolidated and broken out above ₹1,200-₹1,250, setting a target of ₹1,400 with a stop loss at ₹1,270, also noting Dr Reddy's strength and the overall pharma sector's relative outperformance.”

CA Rudramurthy BV’s track record: 17 graded calls · 95% CI 26–69%